• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DASH4D饮食对2型糖尿病患者血糖控制及血糖变异性的影响:一项随机交叉试验

DASH4D diet for glycemic control and glucose variability in type 2 diabetes: a randomized crossover trial.

作者信息

Fang Michael, Wang Dan, Rebholz Casey M, Echouffo-Tcheugui Justin B, Tang Olive, Wang Nae-Yuh, Mitchell Christine M, Pilla Scott J, Appel Lawrence J, Selvin Elizabeth

机构信息

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD, USA.

出版信息

Nat Med. 2025 Aug 5. doi: 10.1038/s41591-025-03823-3.

DOI:10.1038/s41591-025-03823-3
PMID:40764427
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12373023/
Abstract

The Dietary Approaches to Stop Hypertension (DASH) diet is rich in foods (fruits, vegetables, whole grains) that may reduce hyperglycemia and glycemic variability. In this randomized crossover feeding trial, 89 participants with type 2 diabetes were fed four isocaloric diets in a random order: the DASH4D diet (a DASH-style diet tailored for diabetes) or a comparison (typical American) diet, each with higher (3,700 mg day at 2,000 kcal) or lower (1,500 mg day at 2,000 kcal) sodium. Each feeding period lasted 5 weeks. The primary outcomes were mean glucose; percentage of time spent with glucose between 70 and 180 mg dl (time in range); and coefficient of variation assessed using 14 days of continuous glucose monitoring during each feeding period. The DASH4D (versus comparison) diet significantly reduced mean glucose (mean difference = -11.1 mg dl; P < 0.001), increased time in range (mean difference = +5.2 percentage points; P < 0.001) and had no effect on the coefficient of variation (P = 0.52). In analyses of secondary outcomes, glucose standard deviation and time spent with hyperglycemia (glucose >180 mg dl and >250 mg dl) were lower in the DASH4D diet, but time spent with hypoglycemia (glucose <70 mg dl and <54 mg dl) was similar across diets. There were no serious adverse events related to continuous glucose monitoring or the study diets. These results suggest that the DASH4D diet is a promising nutritional approach to substantially improve glycemic control in adults with type 2 diabetes. ClinicalTrials.gov registration: NCT04286555 .

摘要

终止高血压膳食方法(DASH)饮食富含可能降低高血糖和血糖变异性的食物(水果、蔬菜、全谷物)。在这项随机交叉喂养试验中,89名2型糖尿病参与者被随机安排依次食用四种等热量饮食:DASH4D饮食(一种为糖尿病量身定制的DASH式饮食)或对照(典型美式)饮食,每种饮食又分为高钠(2000千卡时3700毫克/天)或低钠(2000千卡时1500毫克/天)两种。每个喂养期持续5周。主要结局指标为平均血糖;血糖在70至180毫克/分升之间的时间百分比(血糖处于目标范围的时间);以及在每个喂养期使用14天连续血糖监测评估的变异系数。DASH4D(与对照相比)饮食显著降低了平均血糖(平均差值=-11.1毫克/分升;P<0.001),增加了血糖处于目标范围的时间(平均差值=+5.2个百分点;P<0.001),且对变异系数无影响(P=0.52)。在次要结局分析中,DASH4D饮食的血糖标准差和高血糖(血糖>180毫克/分升和>250毫克/分升)持续时间较低,但各饮食间低血糖(血糖<70毫克/分升和<54毫克/分升)持续时间相似。未出现与连续血糖监测或研究饮食相关的严重不良事件。这些结果表明,DASH4D饮食是一种有望显著改善2型糖尿病成年人血糖控制的营养方法。临床试验.gov注册号:NCT04286555 。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bfb/12373023/44522afd15f2/nihms-2100872-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bfb/12373023/8242ad666f9a/nihms-2100872-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bfb/12373023/221136255ed6/nihms-2100872-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bfb/12373023/41bed25bf5e6/nihms-2100872-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bfb/12373023/44522afd15f2/nihms-2100872-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bfb/12373023/8242ad666f9a/nihms-2100872-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bfb/12373023/221136255ed6/nihms-2100872-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bfb/12373023/41bed25bf5e6/nihms-2100872-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bfb/12373023/44522afd15f2/nihms-2100872-f0004.jpg

相似文献

1
DASH4D diet for glycemic control and glucose variability in type 2 diabetes: a randomized crossover trial.DASH4D饮食对2型糖尿病患者血糖控制及血糖变异性的影响:一项随机交叉试验
Nat Med. 2025 Aug 5. doi: 10.1038/s41591-025-03823-3.
2
Dietary Patterns, Sodium Reduction, and Blood Pressure in Type 2 Diabetes: The DASH4D Randomized Clinical Trial.2型糖尿病患者的饮食模式、钠摄入减少与血压:DASH4D随机临床试验
JAMA Intern Med. 2025 Jun 9. doi: 10.1001/jamainternmed.2025.1580.
3
Design of the Continuous Glucose Monitoring (CGM) Study in the Dietary Approaches to Stop Hypertension for Diabetes Trial (DASH4D-CGM).糖尿病预防高血压饮食试验(DASH4D-CGM)中持续葡萄糖监测(CGM)研究的设计
Contemp Clin Trials. 2025 Apr;151:107845. doi: 10.1016/j.cct.2025.107845. Epub 2025 Feb 12.
4
Perioperative glycaemic control for people with diabetes undergoing surgery.手术治疗糖尿病患者的围手术期血糖控制
Cochrane Database Syst Rev. 2023 Aug 1;8(8):CD007315. doi: 10.1002/14651858.CD007315.pub3.
5
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.糖尿病合并妊娠:内分泌学会与欧洲内分泌学会联合临床实践指南
J Clin Endocrinol Metab. 2025 Jul 13. doi: 10.1210/clinem/dgaf288.
6
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.孕前糖尿病与妊娠:内分泌学会和欧洲内分泌学会联合临床实践指南
Eur J Endocrinol. 2025 Jun 30;193(1):G1-G48. doi: 10.1093/ejendo/lvaf116.
7
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.用于心血管疾病一级和二级预防的饮食预防高血压(DASH)方案。
Cochrane Database Syst Rev. 2025 May 6;5(5):CD013729. doi: 10.1002/14651858.CD013729.pub2.
8
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
9
Intrapartum Glycemic Control with Insulin Infusion versus Rotating Fluids: A Randomized Controlled Trial.胰岛素输注与轮换液体用于产时血糖控制的随机对照试验
Am J Perinatol. 2025 Aug;42(11):1491-1499. doi: 10.1055/a-2510-4906. Epub 2025 Feb 10.
10
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.胆碱酯酶抑制剂治疗血管性痴呆和其他血管性认知障碍:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Feb 22;2(2):CD013306. doi: 10.1002/14651858.CD013306.pub2.

本文引用的文献

1
Dietary Patterns, Sodium Reduction, and Blood Pressure in Type 2 Diabetes: The DASH4D Randomized Clinical Trial.2型糖尿病患者的饮食模式、钠摄入减少与血压:DASH4D随机临床试验
JAMA Intern Med. 2025 Jun 9. doi: 10.1001/jamainternmed.2025.1580.
2
Design of the Continuous Glucose Monitoring (CGM) Study in the Dietary Approaches to Stop Hypertension for Diabetes Trial (DASH4D-CGM).糖尿病预防高血压饮食试验(DASH4D-CGM)中持续葡萄糖监测(CGM)研究的设计
Contemp Clin Trials. 2025 Apr;151:107845. doi: 10.1016/j.cct.2025.107845. Epub 2025 Feb 12.
3
5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2025.
5. 促进积极的健康行为和福祉以改善健康结局:2025年糖尿病照护标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S86-S127. doi: 10.2337/dc25-S005.
4
Continuous Glucose Monitor Metrics Are Associated with Emergency Department Visits and Hospitalizations for Hypoglycemia and Hyperglycemia, but Have Low Predictive Value.连续血糖监测指标与低血糖和高血糖所致急诊科就诊和住院相关,但预测价值较低。
Diabetes Technol Ther. 2024 May;26(5):298-306. doi: 10.1089/dia.2023.0493. Epub 2024 Mar 22.
5
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2024.6. 血糖目标与低血糖:2024年糖尿病诊疗标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S111-S125. doi: 10.2337/dc24-S006.
6
5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2024.5. 促进积极的健康行为与福祉以改善健康结果:2024年糖尿病护理标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S77-S110. doi: 10.2337/dc24-S005.
7
7. Diabetes Technology: Standards of Care in Diabetes-2024.7. 糖尿病技术:2024年糖尿病护理标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S126-S144. doi: 10.2337/dc24-S007.
8
Adherence to the DASH Diet and Risk of Hypertension: A Systematic Review and Meta-Analysis.坚持 DASH 饮食与高血压风险:系统评价和荟萃分析。
Nutrients. 2023 Jul 24;15(14):3261. doi: 10.3390/nu15143261.
9
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.连续血糖监测及其临床试验指标:国际共识声明。
Lancet Diabetes Endocrinol. 2023 Jan;11(1):42-57. doi: 10.1016/S2213-8587(22)00319-9. Epub 2022 Dec 6.
10
Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.多中心、随机对照试验:仿生胰腺在 1 型糖尿病中的应用。
N Engl J Med. 2022 Sep 29;387(13):1161-1172. doi: 10.1056/NEJMoa2205225.